Clinical Laboratory (Testing / Safety) Expert Witnesses: 4

EXPERTISE IN: 1. The pathobiology, clinico-pathologic correlation, and histopathologic diagnosis of: diseases of the esophagus, stomach, small intestine, colon, rectum, anus, liver, and pancreas. 2. Human neoplasms (cancer) and preneoplastic conditions. 3. Establishing standard of care, causation and cause of death. 

BACKGROUND: 

1. Anatomic Pathology Residency: Washington Univ-Barnes Hospital 1991-94.
2. Oncologic Pathology Fellowship: M.D. Anderson Cancer Center 1994-95.
3. Gastrointestinal and Liver Pathology Fellowship: Harvard-Brigham & Womens Hospital 1995-96.
4. Instructor at Harvard Medical School: 1996-1998.
5. Assistant Professor and Director of Gastrointestinal Pathology Division at UT-Health Science Center-Hermann Hospital, Houston Medical Center: 08/1998 - 12/2000.
6. Staff GI Pathologist and Quality Assurance Director at Caris/Miraca Life Sciences, Dallas TX: 01/2001 - 04/2012.
7. Staff Pathologist, Anatomic Pathology Division of the North Shore-LIJ Health System, Long Island NY: 05/2013 - 05/2015.
8. Staff Pathologist, Anatomic Pathology Division of Alliance Health Sciences, Dallas TX: 01/2016 - present.
9. Sole Proprietor of Expert Pathology Consultation Services Laboratory since 01/2001, which provides diagnostic pathology services to hundreds of clinicians of different subspecialties.         

Dr. Torres was instrumental in creating a unique model of Gastrointestinal Pathology subspecialty-focused laboratory, during his tenure at Caris/Miraca Life Sciences.

Gary D. Fletcher, PhD,  is the Founder and Principal Consultant at RnDDx Solutions LLC, a consulting firm founded in 2015, focused on Industrial Mechanical Engineering and Biomedical Engineering and Research and Product Development.  In his 30 years of experience, he has been co-inventor on 23 patents for devices and methods in blood collection and processing.

Litigation Support - Dr. Fletcher has subject matter expertise in Medical Device Mechanical Engineering and subject matter expertise in Medical Devices for blood and specimen collection and sample processing for in vitro diagnostics, point of care diagnostics, and therapeutics, including glucose monitoring. He serves as an expert witness in patent infringement cases involving medical device and diagnostic biomedical engineering, blood collection, separation, fluidic preparation, glucose monitoring, and cell therapy preparation devices.

Dr. Fletcher offers patent litigation services to law firms and lawyers supporting medical device and diagnostic industry clients, who need physical science and mechanical and biomedical engineering expertise for District Court, PTAB, and ITC patent cases. As an industry consultant, his ideal clients are R&D, product development, and innovation leaders in startup, emerging, and established medical device and diagnostic companies, who face product development and competitive challenges.

Areas of Expertise:

Dr. Fletcher is an entrepreneurial executive with expanding R&D roles in business, technology, and new product development leadership and execution, building and guiding teams in both Fortune 500 and startup companies. With a PhD in physics from Yale, he has a proven record of leadership in creating innovative new businesses and products in healthcare, medical devices, diagnostics, life, materials, and optical sciences.

George Schiro is a DNA Technical Leader - Forensic Scientist. His duties include incorporating the DNA Advisory Board (DAB) standards, accountability for the technical operations of the lab, conducting DNA analysis using the 13 STR core loci and Y STR in casework, DNA research, forensic science training and crime scene investigation.

Mr. Schiro has worked over 3500 cases and has qualified as an expert over 175 times in 31 Louisiana parish courts, Arkansas, California, Florida, Mississippi, Missouri, Nevada, New York, Texas, West Virginia, federal court, U.S. court-martial, and two Louisiana city courts. Has also consulted on cases in 29 states.

Qualified as an Expert in the Following Areas:

Dr. Michael L. Dourson has a PhD in Toxicology from the University of Cincinnati, College of Medicine, and is a board-certified toxicologist (i.e., DABT) with over 40 years of experience in Environmental Risk Assessment. 

Dr. Dourson serves as President/Director of the 501c3 nonprofit organization Toxicology Excellence for Risk Assessment (TERA). Prior to this, he was Senior Advisor in the Office of the Administrator at the US EPA. Before this, he was a Professor in the Risk Science Center at the University of Cincinnati, College of Medicine and also worked at TERA and US EPA. 

Litigation Support - Dr. Dourson's specialized knowledge of the issues and pitfalls involved in the research and development of human health risk assessments along with his cutting-edge toxicology expertise allows him to provide state-of-the-art science assessments for attorneys representing plaintiff and defense. 

Services:

• Review toxicity data to assist in determining whether an exposure was the proximate cause of health effects;
• Perform literature searches and providing written critical analysis of literature;
• Provide services related to expert witness opinions and testimony;
• Review and analyzing environmental monitoring data;
• Assist with the development of exposure and medical monitoring programs; and
• Plan and manage peer review and peer consultation programs.

Areas of Expertise:

Dr. Dourson has been awarded the Arnold J. Lehman award from the Society of Toxicology, the International Achievement Award by the International Society of Regulatory Toxicology and Pharmacology, and 4 bronze medals from the U.S. Environmental Protection Agency. He has been elected as a Fellow of the Academy of Toxicological Sciences (i.e., FATS) and as a Fellow for the Society for Risk Analysis (i.e., FSRA).

He is the co-author of 3 Patty’s Toxicology chapters on PFAS chemistries and the co-author of 6 research papers on PFOA, two of which have won paper of the year awards from the Society of Toxicology’s Regulatory and Safety Evaluation Specialty Section.